Skip to main content

What the FDA labels say about taking them together

Apixaban and rifampin

Apixaban's FDA label of April 24, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name apixaban. The apixaban label: “Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers because such drugs will decrease exposure to apixaban.”

Check it at the source: the apixaban FDA label on DailyMed (effective April 24, 2026, Cardinal Health 107, LLC); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the apixaban label say about rifampin?

Apixaban label, drug interactions

Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) because such drugs will decrease exposure to apixaban [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (ELIQUIS), NDA202155 (Bristol Myers Squibb), as published by Cardinal Health 107, LLC, effective April 24, 2026 (SPL set a454cd24-0c6d-46e8-b1e4-197388606175), via openFDA; the full label on DailyMed

What does the rifampin label say about apixaban?

Rifampin's label (effective February 11, 2026) does not name apixaban in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Apixaban generic labelers
13Rifampin generic labelers
ApixabanRifampin
Labeled forAtrial fibrillation, Blood clots (DVT and PE), Stroke preventionn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$5.52 per tablet 5 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?